IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RIMOLDI, ISABELLA SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.590
EU - Europa 9.586
AS - Asia 9.238
Continente sconosciuto - Info sul continente non disponibili 1.224
SA - Sud America 868
AF - Africa 187
OC - Oceania 55
Totale 31.748
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.130
SG - Singapore 2.711
IT - Italia 2.657
CN - Cina 2.567
GB - Regno Unito 2.211
DE - Germania 1.015
SE - Svezia 886
BD - Bangladesh 840
HK - Hong Kong 735
RU - Federazione Russa 679
BR - Brasile 637
VN - Vietnam 625
IN - India 559
FR - Francia 444
IE - Irlanda 319
CA - Canada 293
KR - Corea 259
NL - Olanda 247
FI - Finlandia 244
TR - Turchia 200
JP - Giappone 195
ES - Italia 183
DK - Danimarca 170
ID - Indonesia 169
UA - Ucraina 122
PL - Polonia 66
CO - Colombia 63
CH - Svizzera 61
MX - Messico 59
AT - Austria 57
BE - Belgio 53
CI - Costa d'Avorio 53
PK - Pakistan 53
AR - Argentina 50
IR - Iran 45
AU - Australia 44
EU - Europa 40
TW - Taiwan 40
PH - Filippine 37
ZA - Sudafrica 33
CL - Cile 32
IQ - Iraq 31
EC - Ecuador 29
GR - Grecia 29
CZ - Repubblica Ceca 27
VE - Venezuela 26
MY - Malesia 24
CR - Costa Rica 22
MA - Marocco 21
RO - Romania 21
IL - Israele 20
SA - Arabia Saudita 20
UZ - Uzbekistan 18
JM - Giamaica 17
TH - Thailandia 17
DZ - Algeria 16
EG - Egitto 15
AZ - Azerbaigian 13
SC - Seychelles 13
PT - Portogallo 12
TT - Trinidad e Tobago 12
AL - Albania 11
NO - Norvegia 11
NZ - Nuova Zelanda 11
PE - Perù 11
HN - Honduras 10
LT - Lituania 10
NP - Nepal 10
BG - Bulgaria 9
HU - Ungheria 9
GT - Guatemala 7
PY - Paraguay 7
SV - El Salvador 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
JO - Giordania 6
PA - Panama 6
TN - Tunisia 6
BB - Barbados 5
HR - Croazia 5
KE - Kenya 5
LU - Lussemburgo 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
UY - Uruguay 5
BZ - Belize 4
LB - Libano 4
LV - Lettonia 4
MD - Moldavia 4
NG - Nigeria 4
PR - Porto Rico 4
BH - Bahrain 3
CM - Camerun 3
DM - Dominica 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MV - Maldive 3
Totale 30.515
Salva come PNG Salva come JPEG
Città #
Southend 1.907
Singapore 1.613
Ashburn 1.124
Dallas 993
Milan 874
San Jose 612
Hong Kong 599
Chandler 563
Council Bluffs 466
Beijing 445
Fairfield 416
Santa Clara 411
Seattle 335
Los Angeles 300
Dublin 281
Wilmington 280
Hefei 256
Ann Arbor 253
Princeton 241
Frankfurt am Main 239
Houston 227
Woodbridge 218
New York 214
Ho Chi Minh City 200
Bengaluru 190
Cambridge 180
Munich 167
Hanoi 154
Lauterbourg 139
Helsinki 137
Buffalo 126
Moscow 125
Boardman 122
Jakarta 121
Nanjing 115
Guangzhou 111
Seoul 111
Rome 103
Tokyo 101
Phoenix 91
Toronto 89
Bologna 88
Dearborn 81
Columbus 80
Des Moines 80
Naples 77
Jacksonville 75
Shanghai 65
Mountain View 63
Redmond 59
Redwood City 59
São Paulo 56
Istanbul 55
Medford 55
Abidjan 53
Berlin 53
Chicago 49
Turin 46
Brussels 45
Cangzhou 45
Florence 45
Padova 45
Shenzhen 45
The Dalles 45
Hangzhou 44
Jinan 43
Andover 41
Bogotá 41
Changsha 41
Nuremberg 40
London 39
San Diego 38
Tianjin 38
Shenyang 37
Kent 36
Kolkata 36
Orem 36
Atlanta 35
Karlsruhe 34
Montreal 34
Brescia 33
Roxbury 33
Somerville 33
Serra 31
Bergamo 30
Da Nang 30
Nanchang 30
Sakarya 30
Zhengzhou 30
Warsaw 29
Lappeenranta 28
Rio de Janeiro 28
Vienna 28
Amsterdam 27
Boston 27
Haiphong 27
San Francisco 27
Fremont 26
Turku 26
Wuhan 26
Totale 17.805
Salva come PNG Salva come JPEG
Nome #
An in vivo active 1,2,5-oxadiazole Pt(II) complex : a promising anticancer agent endowed with STAT3 inhibitory properties 451
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest 437
Amphiphilic Pt(II) complexes for in vivo bioimaging applications 434
Artificial metalloenzymes based on vancomycin for stereoselective catalysis in aqueous media 389
Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in PtII complexes on human carcinoma cell lines: A comparative study with cisplatin 355
1,4-bis-difosfino-(Z)-2-buteni, 1,4 disostituiti otticamente puri in qualità di leganti chirali per la catalisi omogenea stereocontrollata con metalli di transizione 349
Water soluble Ir-complexes for ECL signal amplification in pathogens detection 315
Simple 1,3-diamines and their application as ligands in ruthenium(ii) catalysts for asymmetric transfer hydrogenation of aryl ketones 315
Efficient methodology to produce a duloxetine precursor using whole cells of Rhodotorula rubra 313
Fluorinated dichloride platinum complexes: a new series of promising anticancer agents against orphan tumors 311
Luminescent amphiphilic Pt(II) complexes and their assemblies 309
Self-assembly in vivo: imaging and reactivity 307
Sensitivity of mesenchymal stromal cells to a new imidazole-based cationic Pt(II) complex with high in vitro anticancer activity 305
Conventional and non-conventional catalytic systems for the asymmetric reduction of cyclic imines 304
VCD spectroscopy as an excellent probe of chiral metal complexes containing a carbon monoxide vibrational chromophore 303
Antiproliferative effects of chalcones on T cell acute lymphoblastic leukemia‐derived cells: Role of PKCβ 301
Ruthenium(II) complexes bearing (NNN) ligand : catalytic evaluation of different solvent-mediated coordination modes 299
Novel 3,3-disubstituted oxindole derivatives. Synthesis and evaluation of the anti-proliferative activity 298
Novel platinum agents and mesenchymal stromal cells for thoracic malignancies : state of the art and future perspectives 294
Monofunctional Pt(II) complexes based on 8-aminoquinoline: synthesis and pharmacological characterization 289
Self-assembled complex promotes cell proliferation and stem cell self-renewal through redox signaling in in vivo model 289
A tandem MS precursor-ion scan approsch to identify variable covalent modification of albumin Cys34 : a new tool for studyng vascular carbonylation 286
Enantioselective transfer hydrogenation of aryl ketones: synthesis and 2D-NMR characterization of new 8-amino-5,6,7,8-tetrahydroquinoline Ru(II)-complexes 281
Electrochemiluminescent multinuclear metal complexes for diagnostics 277
“In situ” Activation of Racemic RuII Complexes: Separation of trans and cis Species and Their Application in Asymmetric Reduction 275
Cascade Reaction by Chemo- and Biocatalytic Approaches to Obtain Chiral Hydroxy Ketones and anti 1,3-Diols 275
Anticancer platinum(II) complexes bearing N-heterocycle rings 275
Exploring the copper binding ability of Mets7 hCtr‐1 protein domain and His7 derivative: An insight in Michael addition catalysis 274
Evaluation of chemical diversity of biotinylated chiral 1,3-diamines as a catalytic moiety in artificial imine reductase 270
Malignant Pleural Mesothelioma : State of the art and advanced cell therapy 265
Anticancer platinum‑drug delivered by mesenchymal stromal cells improves its activity on glioblastoma 264
One-pot catalytic strategies for the efficient and enantioselective synthesis of L-Carnosine 262
Cytotoxic platinum(II) complexes bearing N-heterocycle rings as novel theranostic agents 262
Synthesis and crystallographic structure of nickel(0) carbonyl complex with Bitianp, an atropoisomeric diphosphine 257
Catalytic Applications for Heavy Metals Bio-recovery 257
Uptake-release by MSCs of a cationic platinum(II) complex active in vitro on human malignant cancer cell lines 255
Alternative Strategy to Obtain Artificial Imine Reductase by Exploiting Vancomycin/D-Ala-D-Ala Interactions with an Iridium Metal Complex 255
Vancomycin-Iridium (III) Interaction: An Unexplored Route for Enantioselective Imine Reduction 255
Chiral 1,4-bis-diphosphine ligands from optically active (Z)-olefines 254
Luminescent self-assemblies of Pt(II) complexes in vivo 253
Promising antiproliferative platinum(II) complexes based on imidazole moiety: synthesis, evaluation in HCT-116 cancer cell line and interaction with Ctr-1 Met-rich domain 251
8-Amino-5,6,7,8-tetrahydroquinoline in iridium(iii) biotinylated Cp* complex as artificial imine reductase 251
In vitro anticancer activity evaluation of new cationic platinum(II) complexes based on imidazole moiety 246
Luminescent water-soluble cycloplatinated complexes: structural, photophysical, electrochemical and chiroptical properties 245
Enhancing Pt (IV) Complexes Anticancer Activity Upon Encapsulation in Stimuli Responsive Nanocages 242
Cationic platinum(II) complexes active in vivo as anticancer drugs 237
8-Amino-5,6,7,8-Tetrahydroquinolines as Ligands in Iridium(III) Catalysts for the Reduction of Aryl Ketones by asymmetric transfer hydrogenation (ATH) 235
3-(Hydroxy(phenyl)methyl)azetidin-2-ones obtained via catalytic asymmetric hydrogenation or by biotransformation 231
Cationic Pt(II) complex based on 8-aminoquinoline: in vitro activity against human glioblastoma 229
Ni²⁺ and Cu²⁺ Biosorption by EPS-Producing Serratia plymuthica Strains and Potential Bio-Catalysis of the Organo–Metal Complexes 228
Chiral 1,4-diphosphines, 1,4-diphosphites and 1,4-diphosphonites from optically active (Z)-olefins as ligands for metal-catalyzed asymmetric hydrogenation and hydroformylation reactions 228
Structural variations on chiral ligands : new chelating diphosphines from optically active (1,4)-(Z)-2-butenes 226
8-Amino-5,6,7,8-tetrahydroquinolines as ligands in iridium(III) catalysts for the reduction of aryl ketones by asymmetric transfer hydrogenation (ATH) 226
Asymmetric reductions of ethyl 2-(benzamidomethyl)-3-oxobutanoate by yeasts 223
DIOPHEP, a chiral diastereoisomer bisphosphine ligands : synthesis and applications in asymmetric hydrogenations 223
Stereoselective synthesis of 1-methylcarbapenem precursors : studies on the diastereoselective hydroformylation of 4-vinyl b-lactam with aminophosphonite–phosphinite and aminophosphine–phosphite rhodium(I) complexes 222
Asymmetric reduction by transition metals complexes and biocatalysts 219
catalisi enantioselettiva : sintesi di istidina non naturale e istidina non naturale deuterata 218
Asymmetric Hydrogenation of prochiral Ketones catalyzed by Ru(II)Cl2diphosphine/diamine system 217
Aminophosphonite-phosphite and aminophosphonite-phosphinite ligands with mixed chirality: preparation and catalytic applications in asymmetric hydrogenation and hydroformylation 217
Analisi farmaceutica 217
The mesenchymal stromal cells increased the activity on glioblastoma of a new delivered anticancer platinum-drug 215
New sp3 diphosphine-based rhodium catalysts for the asymmetric conjugate addition of aryl boronic acids to 3-azaarylpropenones 211
Mesenchymal stromal cells for antineoplastic drug loading and delivery 209
Combined chemical and biocatalytic approach for asymmetric one-pot reactions 207
Vibrational circular dichroism and chiroptical properties of chiral Ir(III) luminescent complexes 207
One-pot reactions in catalysis: a valuable tool for the synthesis of enantiopure intermediates for pharmaceutical applications 206
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase‑B 206
Hybrid Catalysts from Copper Biosorbing Bacterial Strains and Their Recycling for Catalytic Application in the Asymmetric Addition Reaction of B2(pin)2 on α,β-Unsaturated Chalcones 206
Highly efficient morpholine-based organocatalysts for the 1,4-addition reaction between aldehydes and nitroolefins: an unexploited class of catalysts 205
On the relation between carbonyl stretching frequencies and the donor power of chelating diphosphines in nickel dicarbonyl complexes 203
Mets7 motif peptides in coordinative Cu(I) complexes: application in asymmetric Henry reaction 202
Synthesis and anticancer activity of cyclometalated Pt(II) neutral complexes containing curcumin as a bioactive ancillary ligand 201
Chemo- and biocatalytic strategies to obtain phenylisoserine, lateral chain of taxol by asymmetric reduction 199
Diastereoselectivity and catalytic activity in ruthenium complexes chiral at the metal centre 199
Hystidine and deuterium labelled hystidine by catalytic reduction with Rh(I)-diphosphine complexes and non coordinating strong acids. 198
Amphiphilic Pt(II) complex for in vivo imaging applications 197
Luminescent chiral ionic Ir(III) complexes : synthesis and photophysical properties 197
In Vitro Activity of Monofunctional Pt-II Complex Based on 8-Aminoquinoline against Human Glioblastoma 197
Fast-dissolving mucoadhesive microparticulate delivery system containing piroxicam 192
New Mets7 motif metallopeptide catalysts for Cu(I)-catalyzed asymmetric Henry reaction 191
An oxadiazole Pt(II) complex with promising in vivo antitumor activity 191
Stimuli-responsive luminophore drives mechanism switch for highly efficient electrochemiluminescence immunosensing 189
Aminoquinoline-based Ruthenium catalyst for reduction of ketones by hydrogen transfer 189
A new artificial reductase based on the D-Ala-D-Ala/Vancomycin supramolecular interaction and its applications in the enantioselective reduction of cyclic imines 188
Biological Properties of New Chiral 2-Methyl-5,6,7,8-tetrahydroquinolin-8-amine-based Compounds 188
New chiral ligands for the enantioselective catalysis with transition metal complexes 187
Exploitation of Dimeric Cyclic Cysteine as Helix Inducer in Ultra‐Short Peptides for Cu(II)‐Catalyzed Asymmetric Michael Addition on Chalcones 186
difosfine chelanti innovative e loro applicazioni in catalisi asimmetrica. 186
Aminoquinoline-based Ruthenium catalyst for reduction of ketones by hydrogen transfer 186
STAT3 direct inhibitors: from MD77 to AC33 185
Histidine and deuterium labelled histidine by asymmetric catalytic reduction with gaseous H-2 or D-2 : the role of strong non-coordinating acids 184
Recycling of copper contaminants from wastewater as new hybrid catalysts for the synthesis of valuable pharmaceutical intermediates 183
"In situ" activation of racemic Ru(II) complexes : separation of trans and cis species and their application in asymmetric reduction 182
Alizarin as a selective carrier in cytotoxic Pt(II) complexes toward Triple Negative Breast Cancer (TNBC) 179
Oxadiazole Pt(II) complexes: promising STAT3 inhibitors in cancer therapy 179
A new series of fluorinated dichloride platinum complexes as promising anticancer agents against orphan tumors 179
Ctr-1 Mets7 motif inspiring new peptide ligands for Cu(i)-catalyzed asymmetric Henry reactions under green conditions 178
Asymmetric Hydrogenation of 1-aryl substituted-3,4-Dihydroisoquinolines with Iridium Catalysts Bearing Different Phosphorus-Based Ligands 177
Chiral Aminophosphonite-phosphite and Aminophosphonite-phosphinite Ligands in Asymmetric Hydroformylation of Carbapenem Antibiotics Precursors. 169
Totale 24.383
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.048 0 0 85 140 187 161 192 134 308 157 194 490
2022/20232.568 341 253 237 207 259 400 76 191 258 62 185 99
2023/20241.829 77 148 112 111 316 104 139 164 48 132 232 246
2024/20254.723 188 425 212 474 399 273 260 431 266 398 481 916
2025/202611.720 994 845 1.630 939 1.059 723 1.349 487 1.051 660 1.049 934
2026/20271.388 601 616 171 0 0 0 0 0 0 0 0 0
Totale 31.748